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ABSTRACT
Objective: In the present study, acute toxicity studies were evaluated on scientifically developed nephroprotective polyherbal formulation. Polyherbal 
formulation consists of ethanolic extracts of dried plants of Boerhavia diffusa (BD) and Achyranthes aspera (AA).
Materials and Methods: In an acute toxicity study, polyherbal formulation was administered once orally at doses ranging from 250 mg/kg to 
2000 mg/kg for 15 days. Body weight and food consumption were noted during the study period. Behavioral pattern and toxic effects were monitored 
in each group of animals daily. At the end of the study, blood was withdrawn for hematology and biochemical estimations. The animals were then 
sacrificed, and the liver, kidney, heart, and brain were dissected out which were observed for any gross morphological changes. The weights of organs 
were also noted.
Results: The results showed no changes in body weight, organ weight, food intake, hematological parameters, and liver function test when compared 
with control. The organs did not show any evidence of gross morphological changes.
Conclusion: It is concluded that developed polyherbal formulation, at a dose of 2000 mg/kg, is safe for long-term treatment of kidney disorders
Keywords: Polyherbal formulation, Nephroprotective, Acute toxicity, Hematology, Biochemistry, Boerhavia diffusa and Achranthes aspera.
INTRODUCTION
Plants with healing properties have long been used in different 
traditional medicinal systems worldwide, especially the Indian 
plants have been the major resource of medicines throughout the 
vast majority of human history [1]. The interests in medicinal plants 
for healing different diseases originate out of need and experience. 
Herbs represent as an abundant source of secondary metabolites 
and traditional drugs. Medicinal herbs generate various bioactive 
compounds that resist against any disease but possess toxic effects in 
nature. However, the uses of herbal medicines have been restricted by 
an inadequate chemical characterization, dose regimen, and required 
toxicity data to assess their safety. Hence, it has become important 
to evaluate the safety of plants used for medicinal values for possible 
toxicity [2,3].
The polyherbal formulation contains two or more herbs with 
diverse phytoconstituents possessing similar or dissimilar curative 
potential have been collectively producing enviable effects during 
the administration of human ailments. The present research work 
designed to evaluate a toxic effect of novel polyherbal formulation 
containing extracts of selected plants (Boerhavia diffusa [BD] and 
Achyranthes aspera [AA]) possessing active phytoconstituents which 
were scientifically confirmed for the treatment of kidney diseases [6].
BD Linn. is a herbaceous plant belongs to family Nyctaginaceae. The 
whole plant or its specific parts (leaves, stem, and roots) are known 
to be an important historical, traditional medicine practicing by tribal 
population for long days. The medicinal property of this plant on various 
human diseases is mentioned in Ayurveda. Diuretic, anti-inflammatory, 
antioxidant activities of BD considered as therapeutic potential for the 
treatment of renal inflammatory diseases and complications such as 
ascites, nephrotic syndrome, and edema. Therefore, it is observed that 
BD ameliorates renal function and may prevent the renal cell against 
chemical-induced toxic effects [7].
AA Linn. (Family Amaranthaceae) is an erect stiff medicinal plant. 
AA possesses antimicrobial, antioxidant, diuretic, nephroprotective, 
wound healing, hepatoprotective, immunomodulatory, antiallergic, 
anticarcinogenic, antiulcerogenic, anti-inflammatory, antiarthritic, and 
antidiarrhea activities [8].
MATERIALS AND METHODS
The plants were procured from the Coimbatore district of Tamil Nadu, 
India. Authentication of plant material was carried out at the herbarium 
center of the Botanical Survey of India, Coimbatore, Tamil Nadu, India.
Preparation of plant extract
The fresh plant parts were washed with a running tap water and shade 
dried. The plant materials were crushed to coarse powder. An equal 
proportion of herbal formulation is subjected to successive extraction 
in 70% ethanol solvent by Soxhlet apparatus. The solvent of crude 
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Kidney failure is one of the most common diseases in India. The World 
Health  Organization identifies  four  major  groups of  renal 
failure, according to morphological modifications as, i) glomerular
 diseases,  ii)  tubular  diseases,  iii)  interstitial  diseases,  and  iv) 
vascular  diseases.  The  two  main  types  are  as  follows:  a)  acute  renal 
failure  is  a  syndrome  characterized  by  prompt  onset  of  renal 
dysfunction,  mostly  oliguria  or  anuria,  and  sudden  increase  in 
metabolic waste product in the blood and b) chronic renal failure is a 
syndrome characterized by progressive and irreversible degeneration of
 renal function due to slow destruction of renal parenchyma resulting
 in  death.  Traditional  knowledge  will  serve  as  a  powerful 
search engine and most importantly, facilitate focused and safe,
 natural  products  research  to  rediscover  the  drug  discovery 
process.  Wide variety of plants and its active principles,  with minimal 
side  effects,  provides  an  alternate  therapy  for  kidney  diseases. 
Therefore,  the  searches  of  nephroprotective  herbs  from 
medicinal plants have become important and need of the day [4,5].
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extract was collected evaporated and it was stored and then it was used 
for further analysis [9].
Experimental animals
8–12-week-old albino rats were selected after physical and behavioral 
examination. The body weight range was fallen within 120-150g ±20% 
of the mean body weight at the time of randomization and grouping. 
The animal purchased from M/s. Venkateshwara Enterprises Pvt. 
Ltd., Bangalore. The experimental procedure was approved by the 
Institutional Animal Ethical Committee as per the regulation of the 
board for the Purpose of Control and Supervision of Experiments on 
Animals, Ministry of Environment and Forest, Government of India 
(KMCRET/PhD/01/2018-19) was housed in the standard laboratory 
condition in polypropylene cages, provided with food and water 
ad libitum.
Acute toxicity studies
A preliminary study was conducted to assess acute oral toxicity of 
polyherbal formulation which was administered as a suspension in 
water. Albino rats of either sex were randomly distributed to five 
different groups with six animals in each group. The animals fasted 
overnight, and the drug was administered orally at the dose of 250, 750, 
1500, and 2000 mg/kg of body weight as a suspension in water. The 
animals were observed for mortality (twice daily) and clinical signs for 
the first 30 min after dosing and thereafter once a day for continuous 







This study was carried out in accordance with the Organisation for 
Economic Co-operation and Development (OECD) guidelines for 
testing of chemicals, toxicity guideline no. 420, acute oral toxicity, 
and fixed-dose method [10]. Blood was withdrawn at the end of the 
study. Hematological parameters such as hemoglobin, red blood cell 
count [11], white blood cell count [12], packed cell volume, differential 
leukocyte count, and mean corpuscular hemoglobin were estimated 
using the autoanalyzer [13]. Serum was separated from the blood by 
centrifugation, and biochemical parameters such as serum aspartate 
aminotransferase, serum alanine aminotransferase, and alkaline serum 
phosphatase [14] were estimated. The animals were then sacrificed, 
and the liver, heart, kidney, and brain were dissected out. The organs 
were weighed and were observed for any gross changes [15].
Statistical analysis
The data of all the parameters were analyzed using the software GraphPad 
Prism 5. Analysis of variance (ANOVA), one-way ANOVA followed by 
Dunnett’s test, was performed. The values were expressed as mean±SEM.
RESULTS
Physical and behavioral changes
Albino rats administered with polyherbal formulation up to 2000 mg/kg 
did not show any kind of abnormal physical and general behavior (Table 1), 
during initial 4 h after drug administration. No mortality was observed 
during 24 h after treatment with polyherbal formulation. The normal 
food intake and water consumption of treated groups were found to 
be unaltered by the polyherbal formulation treatment as there were no 
significant changes in the average food intake and water consumption 
(data not shown) when compared with the controls.
Body weight of animal groups
The rats treated with a polyherbal formulation at the dose of 2000 mg/kg 
of body weights were found to grow and increase in body weight normally, 
and there was no treatment-related change found in the body weight 
gains. Table 2 shows the body weight of rats in acute toxicity study.
Organ weight of animal groups
During the study period, all the animals from all the treated dose groups 
showed comparable organ weight gain with that of the control group. 
Table 3 shows the body weight of rats in acute toxicity study.
Biochemistry parameters
The results of biochemical parameters did not show any significant 
change in the levels when compared with the controls. Table 4 shows 
the biochemical parameters of rats.
Table 1: Physical and behavioral signs of acute toxicity doses of polyherbal formulation on albino rats
S. No Response Head Body Tail
Before After Before After Before After
1 Alertness N N N N N N
2 Grooming A A A A A A
3 Touch response A A A A A A
4 Torch response N N N N N N
5 Pain response N N N N N N
6 Tremors A A A A A A
7 Convulsion A A A A A A
8 Righting reflux N N N N N N
9 Gripping strength N N N N N N
10 Pinna reflux P P P P P P
11 Corneal reflux P P P P P P
12 Writhing A A A A A A
13 Pupils N N N N N N
14 Urination N N N N N N
15 Salivation N N N N N N
16 Skin color N N N N N N
17 Lachrymation N N N N N N
N: Normal, A: Absent, P: Present
Table 2: Effects of acute toxicity doses of polyherbal formulation 
on body weight analysis
Groups Initial body weight (g) Final body weight (g)
Control 142 ± 1.033 160.7 ± 1.606
EXT 250 mg/kg 152 ± 1.155*** 161.8 ± 1.493ns
EXT 750 mg/kg 136 ± 1.155* 148.8 ± 1.778***
EXT 1500 mg/kg 154.7 ± 1.978*** 163.3 ± 1.82ns
EXT 2000 mg/kg 153.2 ± 1.424*** 163.8 ± 1.579ns
EXT: Ethanolic extract of Boerhavia diffusa and Achyranthes aspera. Values are 
expressed as mean ± SEM statistical significance (p) calculated by one-way 
ANOVA followed by Dunnett’s (n = 6); nsp > 0.05, *p < 0.05, **p < 0.01, 
***p < 0.001 calculated by comparing treated groups with the control group
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Hematology parameters
The results of hematological parameters of the treated groups of 
animals did not show any significant alteration in the values when 
compared with the respective controls as shown in Table 5.
DISCUSSION
A variety of herbal preparations has been shown to benefit in treating 
kidney disease. Herbal preparations in spite of being harmless drugs 
need to be authenticated by different toxicity studies before being used 
for consumption. The safeties of the individual herbs of AA and BD are 
well known, but the combined effects of these herbs are unclear. Thus, it 
becomes essential to evaluate the safety and toxicity of the combination 
of these plants (BD&AA) [16]. This preparation consists of ingredients 
of herbal source which has been used as kidney protective agents.
The study parameters of these studies include a comparative 
assessment of general appearance/behavior, morbidity/mortality, body 
weights, food/water consumption, laboratory analysis of hematology, 
and blood biochemistry in the treated and control groups of albino rats. 
The polyherbal formulation is a very effective compound formulation, 
traditionally used for the treatment of kidney diseases. Herbal products 
are globally used by humans and have an implicit exponential rise. 
However, the safety and side effects of these herbal products in the 
modern era are also becoming more apparent. There is a great need 
that regulatory policies on herbal products and medicine need to be 
standardized and strengthened globally [17].
Acute toxicity studies are the platform for risk detection phase 
of safety evaluation. As per the OECD guideline 425, the dose 
2000 mg/kg body weight is assumed to be “unclassified” under the 
toxic range [18,19]. Hence, an additional study with higher doses was 
not performed. The acute study of polyherbal formulation up to the 
dose of 2000 mg/kg body weight did not show any adverse indication 
of toxicity, and hence, it is harmless and safe in oral formulation. There 
was no significant variation in the mean body weight, food intake 
and water consumption, and hematological and biochemical results 
between experimental and control groups throughout the study. This 
study also suggests that the LD50 value of polyherbal formulation is 
>2000 mg/kg body weight of Wister rats, as all the rats survived, and 
there were no abnormalities in their physical and behavioral signs 
during the period of 14 days study.
CONCLUSION
Therefore, the present studies propose that the polyherbal formulation 
developed for its nephroprotective activity at the dose level of 250 mg/kg 
orally, daily once is safe even at a very high dose of 2000 mg/kg for 
treatment of nephropathy.
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Table 3: Effects of acute toxicity doses of polyherbal formulation on organ weights (physical parameter)
Groups Liver weight (mg) Kidney weight (mg) Heart weight (mg) Lungs weight (mg)
L R
Control 7.472±0.356 0.704±0.0114 0.666±0.0180 0.745±0.0565 1.728±0.122ns
EXT 250 mg/kg 6.59±0.415ns 0.574±0.019** 0.607±0.0354 0.715±0.0343 1.33±0.0596ns
EXT 750 mg/kg 7.678±0.788ns 0.596±0.00145* 0.560±0.0078** 0.660±0.0190 1.663±0.1328ns
EXT 1500mg/kg 6.721±0.241ns 0.515±0.0018*** 0.493±0.0043*** 0.79±0.0517 1.627±0.03301ns
EXT 2000mg/kg 6.894±0.2329ns 0.534±0.0596*** 0.466±0.0064*** 0.7543±0.0461 1.291±0.1035*
EXT: Ethanolic extract of Boerhavia diffusa and Achyranthes aspera. Values are expressed as mean±SEM. Statistical significance (p) calculated by one-way ANOVA 
followed by Dunnett’s (n=6); ns p>0.05, *p<0.05, **p<0.01, ***p<0.001 calculated by comparing treated groups with the control group
Table 4: Effect of acute toxicity doses on biochemical parameters
Group Total bilirubin (g/dl) SGOT (U/L) SGPT (U/L) ALP (U/L)
Control 0.21±0.0289 164.8±6.928 56.95±2.511 160.9±13.48
EXT 250 mg/kg 0.31±0.078ns 143.6±14.38 44.95±4.89ns 139±23.38ns
EXT 750 mg/kg 0.34±0.0077ns 149.3±10.68ns 49.45±5.225ns 176.7±0.1155ns
EXT 1500 mg/kg 0.5±0.0115** 197.1±5.889ns 61.75±0.433ns 212.9±6.553*
EXT 2000 mg/kg 0.3±0.0289ns 135.6±4.677ns 47.3±3.175ns 114.7±5.485ns
Oxaloacetate transaminase, SGPT: Serum glutamate pyruvate transaminase, ALP: Alkaline phosphatase. Values are expressed as mean±SEM Statistical significance (p) 
calculated by one-way ANOVA followed by Dunnett’s (n=6); nsp>0.05, *p<0.05, **p<0.01, ***p<0.001 calculated by comparing treated groups with the control group
Table 5: Effect of acute toxicity doses on hematological parameters


















Control 4.96±0.0346 14.1±0.2887 12.35±0.259 38.35±0.664 3.5±0.866 90±1.155 3.5±0.2887 3±0 24.9±0.3464
EXT  
250 mg/kg
4.68±0.092ns 12.45±1.93ns 11.05±0.259* 34±0.9238* 4±0 92±0 2±0 2±0 23.65±0.0866ns
EXT  
750 mg/kg
5.65±0.294ns 14.55±0.6062 12.15±0.1443 37.6±0.4619 7.5±0.2887 85±0.5774 3±0 4.5±0.2887 23.65±0.2598ns
EXT  
1500 mg/kg
4.48±0.1963ns 16.9±0.4041 9.1±0.1732*** 28.85±0.95*** 13±0.5774** 79±0.5774** 4±0.5774 4±0.5774 20.35±0.4907ns
EXT  
2000 mg/kg
4.59±0.2829 15.05±0.1443 9.9±0.461*** 30.75±1.58** 11±2.887* 81±4.041* 3±0.5774 5±0.5774* 21.65±0.3175ns
EXT: Ethanolic extract of Boerhavia diffusa and Achyranthes aspera, RBC: Red Blood Cell, WBC: White Blood Cell, Hb: Hemoglobin, PCV: Packed cell volume, MCH: 
Mean Corpuscular Hemoglobin. Values are expressed as mean ± SEM Statistical significance (p) calculated by one-way ANOVA followed by Dunnett’s (n = 6); ns p>0.05, 
*p<0.05, **p<0.01, ***p<0.001 calculated by comparing
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